CORDIS
EU research results

CORDIS

English EN

Cell death: from basic principles to therapeutic application

Objective

Deregulation of cell death causes many human diseases, e.g. cancer, which represent major social and health challenges. This RTN links up 13 academic and 2 industrial partners of recognised international stature in a well-defined collaborative research project to provide a platform for structured training, transfer of knowledge (ToK) and career development in cell death research. The joint project aims at deciphering molecular mechanisms of cell death to develop better cancer therapies (new prognostic biomarkers, new cancer drugs), relevant to the objective of combating cancer (priority 1, 6th framework program). Translation of new knowledge from bench-to-bedside is fostered by interdisciplinary and intersectorial ToK. Innovation and commercial exploitation is facilitated by academia-industry cooperation including an SME. The network's training program addresses important and timely training/ToK needs and fully exploits the network's interdisciplinary, intersectorial and transeuropean potential, combining loc al specialist with network-wide training adapted to the targeted researchers. Visits/secondments including an industrial placement, education in complementary skills and mentoring should advise trainees on new opportunities for multiple career paths, taking into account the broader needs of the European labour market for researchers. All this contributes to create a new European cadre of researchers with interdisciplinary/intersectorial skills, technical excellence, flexibility and humanity. The network realises European added value by integrating different disciplines, industry-academia cooperation, overcoming fragmentation, structuring the European Research Area through integration of New Member and Associated Countries and less-favoured regions, promoting women in science and by enhancing Europe's attractiveness for researchers and competitivity. Thus, this RTN is expected to yield major breakthroughs in combating cancer with huge socio-economic impact.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

KLINIKUM DER JOHANN WOLFGANG GOETHE-UNIVERSITAET

Address

Theodor-Stern-Kai,7
Frankfurt

Germany

Participants (17)

Sort alphabetically

Expand all

DEUTSCHES KREBSFORSCHUNGSZENTRUM

Germany

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

France

FACULTY OF MEDICINE, UNIVERSITY OF BURGUNDY

France

UNIVERSIT?? DE LAUSANNE

Switzerland

INNSBRUCK MEDICAL UNIVERSITY

Austria

FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW

Belgium

FONDAZIONE ISTITUTO ONCOLOGICO DEL MEDITERRANEO

Italy

MEDICAL RESEARCH COUNCIL

United Kingdom

UNIVERSITY OF MANCHESTER

United Kingdom

THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (HERINAFTER CALLED TCD)

Ireland

NATIONAL UNIVERSITY OF IRELAND GALWAY

Ireland

UNIVERSITY OF DEBRECEN

Hungary

APOTECH CORPORATION

Switzerland

SCHERING AKTIENGESELLSCHAFT

Germany

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

United Kingdom

EXPERIMENTAL PHARMACOLOGY & ONCOLOGY BERLIN-BUCH GMBH

Germany

UNIVERSITAETSKLINIKUM ULM

Germany

Project information

Grant agreement ID: 35624

  • Start date

    1 April 2007

  • End date

    31 March 2011

Funded under:

FP6-MOBILITY

Coordinated by:

KLINIKUM DER JOHANN WOLFGANG GOETHE-UNIVERSITAET

Germany